HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
暂无分享,去创建一个
Terry L. Jernigan | Anthony Gamst | David M. Simpson | Tanya Wolfson | Michael J. Taylor | Robert K. Heaton | Ronald J. Ellis | Ian Abramson | Christine Fennema-Notestine | Susan Morgello | Thomas D. Marcotte | Justin C. McArthur | Joseph Wong | Donald R. Franklin | C. Fennema-Notestine | T. Jernigan | A. Gamst | I. Grant | R. Heaton | D. Clifford | R. Ellis | I. Abramson | T. Wolfson | J. McCutchan | J. Atkinson | T. Marcotte | C. Marra | D. Simpson | J. McArthur | S. Letendre | J. Wong | A. Collier | S. Woods | D. Franklin | S. LeBlanc | B. Gelman | S. Morgello | M. R. Mindt | S. Corkran | N. Duarte | for the Desir and Risc Study Groups | Benjamin B. Gelman | Scott L. Letendre | David B. Clifford | Ann C. Collier | J. Allen McCutchan | Igor Grant | J. Hampton Atkinson | Shannon LeBlanc | Stephanie H. Corkran | Nichole A. Duarte | Steven P. Woods | Christina M. Marra | Monica Rivera Mindt
[1] E. Daar. Faculty Opinions recommendation of HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. , 2011 .
[2] Michael J. Taylor,et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.
[3] J. McArthur,et al. HIV-associated neurocognitive disorders: is there a hidden epidemic? , 2010, AIDS.
[4] Dan J Stein,et al. Does highly active antiretroviral therapy improve neurocognitive function? A systematic review , 2010, Journal of NeuroVirology.
[5] Jean-Marie Annoni,et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia , 2009, AIDS.
[6] F. Vaida,et al. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy , 2009, Neurology.
[7] D. Clifford,et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance , 2009, AIDS.
[8] M. McKenna,et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[9] B. Clotet,et al. Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. , 2008, AIDS research and human retroviruses.
[10] A. Venkatesan,et al. Evolution of HIV dementia with HIV infection , 2008, International review of psychiatry.
[11] A. Winston,et al. Response to "Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment". , 2007, Journal of acquired immune deficiency syndromes.
[12] J. Becker,et al. Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.
[13] Justin C McArthur,et al. The prevalence and incidence of neurocognitive impairment in the HAART era , 2007, AIDS.
[14] P. Narciso,et al. Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. , 2005, AIDS research and human retroviruses.
[15] J. Catalan,et al. Undetectable Cerebrospinal Fluid HIV RNA and β-2 Microglobulin Do Not Indicate Inactive AIDS Dementia Complex in Highly Active Antiretroviral Therapy-Treated Patients , 2005, Journal of acquired immune deficiency syndromes.
[16] I Grant,et al. A multimodal assessment of driving performance in HIV infection , 2004, Neurology.
[17] I. Grant,et al. Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV , 2004, Journal of clinical and experimental neuropsychology.
[18] I. Grant,et al. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders , 2004, Annals of neurology.
[19] Carla J. Reicks,et al. The impact of HIV-associated neuropsychological impairment on everyday functioning , 2004, Journal of the International Neuropsychological Society.
[20] C. Hinkin,et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse , 2004, AIDS.
[21] Bruce J Brew,et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy , 2003, AIDS.
[22] R. Ivnik,et al. Clinical Interpretation of the WAIS-III and WMS-III , 2003 .
[23] Michael J. Taylor,et al. The impact of HIV-related neuropsychological dysfunction on driving behavior , 2000, Journal of the International Neuropsychological Society.
[24] Wilbur L. Smith,et al. Erratum: ″Personality change disorder in children and adolescents following traumatic brain injury,″ (Journal of the International Neuropsychological Society (2000) vol. 6(3) (279-289)) , 1999 .
[25] Michael J. Taylor,et al. The impact of HIV-related neuropsychological dysfunction on driving behavior , 1999, Journal of the International Neuropsychological Society.
[26] J. Becker,et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy , 1999, Neurology.
[27] J. Rabkin,et al. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function , 1998, AIDS.
[28] I. Grant,et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome , 1997, Annals of neurology.
[29] J. McArthur,et al. Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.
[30] B. Brew,et al. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. , 1997, The Journal of infectious diseases.
[31] L. Thal,et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. , 1997, Archives of neurology.
[32] Michael J. Taylor,et al. The HNRC 500-Neuropsychology of Hiv infection at different disease stages , 1995, Journal of the International Neuropsychological Society.
[33] A. Monsch,et al. Neuropsychological studies of asymptomatic Human Immunodeficiency Virus-Type-1 infected individuals , 1995, Journal of the International Neuropsychological Society.
[34] K. Marder,et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment , 1993, Neurology.
[35] D. Richman,et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. , 1987, Annals of internal medicine.
[36] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[37] P. Maruff,et al. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts , 2011, Journal of NeuroVirology.
[38] Yaakov Stern,et al. HIV-associated cognitive impairment before and after the advent of combination therapy , 2011, Journal of NeuroVirology.
[39] A. Steinacker,et al. A Spice Study of Silicon Sensor Strip Noise on Long Ladders , 2011 .
[40] Michael J. Taylor,et al. Demographic Effects and Use of Demographically Corrected Norms with the WAIS-III and WMS-III , 2003 .
[41] G. Chelune,et al. Neuropsychological and Personality Correlates of Patients’ Complaints of Disability , 1986 .
[42] G. Goldstein,et al. Advances in Clinical Neuropsychology , 1986, Advances in Clinical Neuropsychology.